Breast cancer is classified into subtypes of triple-negative (basal-like), luminal A, luminal B, and HER2-overexpressing, which are classified based on the expression of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) [2,3]. This evidence concerns the gene PGR and breast carcinoma.